Heidelberg Pharma AG Statistics

Total Valuation

FRA:HPHA has a market cap or net worth of EUR 220.91 million. The enterprise value is 200.38 million.

Market Cap	220.91M
Enterprise Value	200.38M

Important Dates

The next estimated earnings date is Thursday, July 10, 2025.

Earnings Date	Jul 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	46.60M
Shares Outstanding	n/a
Shares Change (YoY)	+1.47%
Shares Change (QoQ)	-5.70%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	9.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	32.24
PB Ratio	8.81
P/TBV Ratio	13.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-9.62
EV / Sales	29.24
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.17

Financial Position

The company has a current ratio of 7.15, with a Debt / Equity ratio of 0.01.

Current Ratio	7.15
Quick Ratio	4.78
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-592.23

Financial Efficiency

Return on equity (ROE) is -59.35% and return on invested capital (ROIC) is -40.11%.

Return on Equity (ROE)	-59.35%
Return on Assets (ROA)	-26.48%
Return on Invested Capital (ROIC)	-40.11%
Return on Capital Employed (ROCE)	-51.33%
Revenue Per Employee	65,264
Profits Per Employee	-198,337
Employee Count	105
Asset Turnover	0.12
Inventory Turnover	0.15

Taxes

Income Tax	-48,931
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +83.01% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+83.01%
50-Day Moving Average	3.55
200-Day Moving Average	2.75
Relative Strength Index (RSI)	68.41
Average Volume (20 Days)	25,921

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:HPHA had revenue of EUR 6.85 million and -20.83 million in losses. Loss per share was -0.45.

Revenue	6.85M
Gross Profit	5.06M
Operating Income	-24.25M
Pretax Income	-20.87M
Net Income	-20.83M
EBITDA	-23.51M
EBIT	-24.25M
Loss Per Share	-0.45

Full Income Statement

Balance Sheet

The company has 20.68 million in cash and 151,890 in debt, giving a net cash position of 20.53 million.

Cash & Cash Equivalents	20.68M
Total Debt	151,890
Net Cash	20.53M
Net Cash Per Share	n/a
Equity (Book Value)	25.06M
Book Value Per Share	0.54
Working Capital	34.18M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -27.42 million and capital expenditures -507,555, giving a free cash flow of -27.93 million.

Operating Cash Flow	-27.42M
Capital Expenditures	-507,555
Free Cash Flow	-27.93M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	73.80%
Operating Margin	-353.88%
Pretax Margin	-304.62%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:HPHA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.47%
Shareholder Yield	n/a
Earnings Yield	-9.43%
FCF Yield	-12.64%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 7, 2017. It was a forward split with a ratio of 1.0464082038.

Last Split Date	Nov 7, 2017
Split Type	Forward
Split Ratio	1.0464082038

Scores

FRA:HPHA has an Altman Z-Score of -6.89 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.89
Piotroski F-Score	1